Agronomics Limited Announces BlueNalu Expands Partnership with Nomad Foods
Agronomics announces the expansion of its portfolio company BlueNalu's partnership with Nomad Foods to commercialize cell-cultivated seafood in the UK and Europe. The partnership, first established in 2021, will focus on market entry through premium foodservice channels.
BlueNalu has joined the UK Food Standards Agency's regulatory program as the only company focused on cell-cultivated seafood. Recent research shows strong consumer interest, with 92% of UK sushi consumers eager to try BlueNalu's first commercial product, cell-cultivated bluefin tuna toro. Notably, 74% of consumers expressed willingness to pay the same or higher prices compared to conventional bluefin tuna.
Agronomics has invested US$8.0 million in BlueNalu, currently valued at £13.0 million, representing approximately 8.6% of Agronomics' Net Asset Value as of December 2024.
Agronomics annuncia l'espansione della partnership della sua società in portafoglio BlueNalu con Nomad Foods per la commercializzazione di prodotti ittici coltivati in laboratorio nel Regno Unito e in Europa. La collaborazione, avviata nel 2021, si concentrerà sull'ingresso nel mercato attraverso canali di ristorazione di alta gamma.
BlueNalu ha aderito al programma regolatorio dell'Agenzia per gli Standard Alimentari del Regno Unito, risultando l'unica azienda specializzata in prodotti ittici coltivati in laboratorio. Studi recenti evidenziano un forte interesse da parte dei consumatori, con il 92% degli amanti del sushi nel Regno Unito desiderosi di provare il primo prodotto commerciale di BlueNalu, il tonno pinna blu toro coltivato in laboratorio. In particolare, il 74% dei consumatori si è detto disposto a pagare lo stesso prezzo o anche di più rispetto al tonno pinna blu convenzionale.
Agronomics ha investito 8,0 milioni di dollari USA in BlueNalu, attualmente valutata 13,0 milioni di sterline, rappresentando circa l'8,6% del valore netto degli asset di Agronomics a dicembre 2024.
Agronomics anuncia la expansión de la asociación de su empresa en cartera BlueNalu con Nomad Foods para comercializar mariscos cultivados en células en el Reino Unido y Europa. La colaboración, establecida inicialmente en 2021, se enfocará en la entrada al mercado a través de canales de servicios alimentarios premium.
BlueNalu se ha unido al programa regulatorio de la Agencia de Normas Alimentarias del Reino Unido como la única empresa centrada en mariscos cultivados en células. Investigaciones recientes muestran un fuerte interés del consumidor, con un 92% de los consumidores de sushi en el Reino Unido deseosos de probar el primer producto comercial de BlueNalu, el atún azul toro cultivado en células. Notablemente, el 74% de los consumidores expresó su disposición a pagar el mismo precio o incluso más en comparación con el atún azul convencional.
Agronomics ha invertido 8,0 millones de dólares estadounidenses en BlueNalu, valorada actualmente en 13,0 millones de libras esterlinas, representando aproximadamente el 8,6% del valor neto de los activos de Agronomics a diciembre de 2024.
Agronomics는 포트폴리오 회사인 BlueNalu와의 Nomad Foods와의 파트너십을 확장하여 영국 및 유럽에서 세포 배양 해산물 상용화를 추진한다고 발표했습니다. 2021년에 처음 체결된 이 파트너십은 프리미엄 외식 채널을 통한 시장 진입에 중점을 둘 예정입니다.
BlueNalu는 영국 식품 기준청(Food Standards Agency)의 규제 프로그램에 세포 배양 해산물에 집중하는 유일한 회사로 참여했습니다. 최근 연구에 따르면 영국 스시 소비자의 92%가 BlueNalu의 첫 상업 제품인 세포 배양 블루핀 참치 토로를 시도해보고 싶어하는 강한 관심을 보였습니다. 특히 74%의 소비자가 기존 블루핀 참치와 동일하거나 더 높은 가격을 지불할 의향이 있다고 밝혔습니다.
Agronomics는 BlueNalu에 800만 달러를 투자했으며, 현재 가치는 1,300만 파운드로 2024년 12월 기준 Agronomics 순자산가치의 약 8.6%를 차지합니다.
Agronomics annonce l'expansion du partenariat de sa société en portefeuille BlueNalu avec Nomad Foods pour commercialiser des fruits de mer cultivés en laboratoire au Royaume-Uni et en Europe. Ce partenariat, établi initialement en 2021, se concentrera sur l'entrée sur le marché via des canaux de restauration haut de gamme.
BlueNalu a rejoint le programme réglementaire de la Food Standards Agency du Royaume-Uni en tant que seule entreprise spécialisée dans les fruits de mer cultivés en laboratoire. Des recherches récentes montrent un fort intérêt des consommateurs, avec 92 % des consommateurs de sushi au Royaume-Uni désireux d'essayer le premier produit commercial de BlueNalu, le thon rouge toro cultivé en laboratoire. Notamment, 74 % des consommateurs se sont déclarés prêts à payer le même prix ou un prix supérieur à celui du thon rouge conventionnel.
Agronomics a investi 8,0 millions de dollars US dans BlueNalu, actuellement valorisée à 13,0 millions de livres sterling, représentant environ 8,6 % de la valeur nette des actifs d'Agronomics en décembre 2024.
Agronomics gibt die Erweiterung der Partnerschaft seines Portfoliounternehmens BlueNalu mit Nomad Foods zur Kommerzialisierung von zellkultivierten Meeresfrüchten im Vereinigten Königreich und Europa bekannt. Die Partnerschaft, die erstmals 2021 geschlossen wurde, konzentriert sich auf den Markteintritt über Premium-Gastronomiekanäle.
BlueNalu ist dem Regulierungsprogramm der britischen Food Standards Agency als einziges Unternehmen beigetreten, das sich auf zellkultivierte Meeresfrüchte spezialisiert hat. Aktuelle Untersuchungen zeigen ein starkes Verbraucherinteresse: 92 % der Sushi-Konsumenten im Vereinigten Königreich sind daran interessiert, BlueNalus erstes kommerzielles Produkt, zellkultivierten Blauflossen-Thunfisch Toro, zu probieren. Bemerkenswert ist, dass 74 % der Verbraucher bereit sind, den gleichen oder einen höheren Preis als für konventionellen Blauflossen-Thunfisch zu zahlen.
Agronomics hat 8,0 Millionen US-Dollar in BlueNalu investiert, das derzeit mit 13,0 Millionen Pfund bewertet wird und damit etwa 8,6 % des Nettovermögenswerts von Agronomics zum Dezember 2024 ausmacht.
- Strategic partnership expansion with Nomad Foods (Europe's leading frozen food company) to commercialize cell-cultivated seafood in UK/Europe
- 92% of surveyed UK sushi consumers expressed interest in trying BlueNalu's cell-cultivated bluefin tuna
- 74% of consumers willing to pay same or higher prices compared to conventional bluefin tuna
- BlueNalu joined UK Food Standards Agency's regulatory program, potentially accelerating approval process
- Agronomics' investment in BlueNalu has appreciated from £6.1M to £13.0M (represents 8.6% of NAV)
- No immediate revenue generation - still in pre-commercial phase
- Regulatory approval timeline remains uncertain despite FSA program participation
- Limited initial market entry - starting only with premium foodservice and limited-time offerings
DOUGLAS, IM / ACCESS Newswire / April 30, 2025 / Agronomics (LSE:ANIC), a leading listed company in the field of clean food, is delighted to announce that its portfolio company, BlueNalu, Inc ("BlueNalu"), a global leader in cell-cultivated seafood, has expanded its strategic partnership with Nomad Foods Limited ("Nomad Foods"), Europe's leading frozen food company, to support the commercialisation of its cell-cultivated seafood products in the UK and across Europe.
Nomad Foods and BlueNalu first announced their partnership in 2021. To date, the partnership has explored opportunities to bring cell-cultivated seafood to select markets in the UK and Europe. The new partnership will now see the two companies work together on delivering a market-entry strategy for the sale of BlueNalu's cell-cultivated seafood in the UK, beginning with premium foodservice and limited-time offerings that align with consumer demand for high-quality seafood options.
The partnership will also support BlueNalu's ongoing work with the UK Government. In March, the Government announced that BlueNalu had joined the UK Food Standards Agency's ("FSA") pioneering regulatory programme to help speed up the approval process for cultivated-grown foods. The program enables BlueNalu to work collaboratively with the FSA to navigate the regulatory process for novel foods and ensure the highest food safety and transparency standards. BlueNalu is the only company within the program focused primarily on cell-cultivated seafood.
New research sponsored by BlueNalu also reveals strong enthusiasm among UK sushi consumers for cell-cultivated bluefin tuna toro, which will be its first commercial product. In a survey of 2,000 frequent sushi eaters conducted in 2024,
Lou Cooperhouse, Founder, President, and CEO of BlueNalu commented "Our cell-cultivated bluefin toro offers a new, high-quality seafood experience-nutrient-rich, free from environmental contaminants, and designed to complement a global supply chain that is increasingly fragile and unpredictable. We are proud to work with trusted partners and forward-thinking regulatory agencies to deliver safe, consistent, and desirable seafood to consumers in the coming years. Our acceptance into the UK regulatory sandbox reinforces BlueNalu's position as a global company at the forefront of food system innovation."
Jim Mellon, Executive Chair of Agronomics said: "Today's news further exemplifies the ongoing momentum in the cultivated food sector across the globe. This research also confirms what we have known for some time, that there is a strong demand from consumers, who want food options which are not only more sustainable, but ones which are healthier and better for themselves and the planet. We are looking forward to BlueNalu making waves in the UK, as its partnership with Nomad Foods will drive forward innovation in the clean food industry."
To date, Agronomics has invested a total of US
For more information about BlueNalu, please visit www.bluenalu.com.
About BlueNalu
BlueNalu is pioneering the future of seafood by developing premium-quality, cell-cultivated seafood products directly from fish cells. Founded in 2018 and headquartered in San Diego, California, the company combines innovative biotechnology with culinary expertise to deliver seafood products that align with consumer preferences for health, safety, and sustainability. BlueNalu is dedicated to supporting a more resilient global seafood supply chain and reducing pressure on wild fish populations.
About Agronomics
Agronomics is a leading London-listed company focusing on investment opportunities within the field of clean food. The Company has established a portfolio of over 20 companies in this rapidly advancing sector. It seeks to invest in companies owning technologies with defensible intellectual property that offer new ways of producing food and materials with a focus on products historically derived from animals.
These technologies are driving a major disruption in agriculture, offering solutions to improve sustainability, as well as addressing human health, animal welfare and environmental damage. This disruption will decouple supply chains from the environment and animals and improve food security for the world's expanding population. A full list of Agronomics' portfolio companies is available at https://agronomics.im/.
Agronomics Limited | Beaumont Cornish Limited | Canaccord Genuity Limited | Cavendish Capital Markets Limited | Peterhouse Capital Limited | 33Seconds Limited |
The Company | Nomad | Joint Broker | Joint Broker | Joint Broker | Public Relations |
Jim Mellon Denham Eke | Roland Cornish James Biddle | Andrew Potts Harry Pardoe | Giles Balleny Michael Johnson | Lucy Williams Charles Goodfellow | Jack Ferris Calum Warren-Piper |
+44 (0) 1624 639396 | +44 (0) 207 628 3396 | +44 (0) 207 523 8000 | +44 (0) 207 397 8900 | +44 (0) 207 469 0936 |
About Reach announcements
This is a Reach announcement. Reach is an investor communication service aimed at assisting listed and unlisted (including AIM quoted) companies to distribute media only / non-regulatory news releases into the public domain. Information required to be notified under the AIM Rules for Companies, Market Abuse Regulation or other regulation would be disseminated as an RNS regulatory announcement and not on Reach.
This information is provided by Reach, the non-regulatory press release distribution service of RNS, part of the London Stock Exchange. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.
SOURCE: Agronomics Limited
View the original press release on ACCESS Newswire
FAQ
What is the value of Agronomics (AGNMF) investment in BlueNalu as of December 2024?
How did UK consumers respond to BlueNalu's cell-cultivated bluefin tuna in 2024 research?
What is the partnership between BlueNalu and Nomad Foods in Europe for 2025?
What regulatory progress has BlueNalu made in the UK food market?
What are the main benefits of BlueNalu's cell-cultivated bluefin tuna?
